miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1

Shu Chen1, Lianhua Jin2, Shu Nie2

  • 1Department of Thoracic Surgery, The Second Hospital of Jilin UniversityChangchunP.R. China.

Oncology Research
|June 28, 2017
PubMed

Insights

MicroRNA-205 (miR-205) acts as a tumor suppressor in neuroblastoma (NB). Restoring miR-205 inhibits NB cell growth and metastasis by targeting cAMP-responsive element-binding protein 1 (CREB1).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-205 (miR-205) is implicated in various cancers, but its role in neuroblastoma (NB) is not well understood.
  • Neuroblastoma is a pediatric cancer with significant unmet needs in understanding its molecular drivers.

Purpose of the Study:

  • To investigate the function of miR-205 in neuroblastoma.
  • To identify the molecular targets of miR-205 in NB.

Main Methods:

  • Quantitative real-time PCR to measure miR-205 and CREB1 expression in NB tissues and cell lines.
  • In vitro assays (proliferation, migration, invasion, apoptosis) and in vivo tumor xenograft models to assess miR-205 function.
  • Western blotting and luciferase reporter assays to validate CREB1 as a direct target of miR-205.

Main Results:

  • miR-205 was significantly downregulated in NB tissues and cell lines, correlating with advanced stage and poor differentiation.
  • Restoration of miR-205 suppressed NB cell proliferation, migration, invasion, and tumor growth, while inducing apoptosis.
  • cAMP-responsive element-binding protein 1 (CREB1) was identified as a direct target of miR-205; CREB1 was upregulated in NB and inversely correlated with miR-205 levels. Upregulation of CREB1 partially rescued the tumor-suppressive effects of miR-205.

Conclusions:

  • miR-205 functions as a tumor suppressor in neuroblastoma.
  • The tumor-suppressive role of miR-205 in NB is mediated, at least in part, through the inhibition of its direct target, CREB1.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K